These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3839802)

  • 1. Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.
    Bonthron DT; Markham AF; Ginsburg D; Orkin SH
    J Clin Invest; 1985 Aug; 76(2):894-7. PubMed ID: 3839802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.
    Akeson AL; Wiginton DA; States JC; Perme CM; Dusing MR; Hutton JJ
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5947-51. PubMed ID: 3475710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal and mutant human adenosine deaminase genes.
    Akeson AL; Wiginton DA; Hutton JJ
    J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity.
    Valerio D; Dekker BM; Duyvesteyn MG; van der Voorn L; Berkvens TM; van Ormondt H; van der Eb AJ
    EMBO J; 1986 Jan; 5(1):113-9. PubMed ID: 3007108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency.
    Markert ML; Hershfield MS; Wiginton DA; States JC; Ward FE; Bigner SH; Buckley RH; Kaufman RE; Hutton JJ
    J Immunol; 1987 May; 138(10):3203-6. PubMed ID: 3571974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of adenosine deaminase deficiency.
    Markert ML
    Immunodeficiency; 1994; 5(2):141-57. PubMed ID: 8032366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency.
    Shovlin CL; Simmonds HA; Fairbanks LD; Deacock SJ; Hughes JM; Lechler RI; Webster AD; Sun XM; Webb JC; Soutar AK
    J Immunol; 1994 Sep; 153(5):2331-9. PubMed ID: 8051429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte-specific overproduction of adenosine deaminase: molecular genetic studies.
    Chottiner EG; Gribbin TE; Ginsburg D; Mitchell BS
    Prog Clin Biol Res; 1989; 319():55-64; discussion 65-8. PubMed ID: 2622927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
    Hirschhorn R; Yang DR; Insel RA; Ballow M
    Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adenosine deaminase activity and immune dysfunction (author's transl)].
    Bremer H; Bauer I; Brock J
    Allerg Immunol (Leipz); 1981; 27(1):3-13. PubMed ID: 6455054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency.
    Hirschhorn R; Tzall S; Ellenbogen A; Orkin SH
    J Clin Invest; 1989 Feb; 83(2):497-501. PubMed ID: 2783588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine deaminase deficiency.
    Hirschhorn R
    Immunodefic Rev; 1990; 2(3):175-98. PubMed ID: 2078332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunochemical quantitation of human adenosine deaminase.
    Daddona PE; Frohman MA; Kelley WN
    J Clin Invest; 1979 Sep; 64(3):798-803. PubMed ID: 468994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine deaminase deficiency and immunodeficiencies.
    Hirschhorn R
    Fed Proc; 1977 Jul; 36(8):2166-70. PubMed ID: 872949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
    Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
    J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
    Uberti J; Peterson WD; Lightbody JJ; Johnson RM
    J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cDNA and amino acid sequence of human adenosine deaminase.
    Daddona PE; Orkin SH; Shewach DS; Kelley WN
    Ann N Y Acad Sci; 1985; 451():238-44. PubMed ID: 3878119
    [No Abstract]   [Full Text] [Related]  

  • 18. [Severe combined immunodeficiency with adenosine deaminase deficiency (author's transl)].
    Allepuz Llop N; Pellejá Pellejá J
    An Esp Pediatr; 1982 May; 16(5):421-5. PubMed ID: 7114620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five missense mutations at the adenosine deaminase locus (ADA) detected by altered restriction fragments and their frequency in ADA--patients with severe combined immunodeficiency (ADA-SCID).
    Hirschhorn R; Ellenbogen A; Tzall S
    Am J Med Genet; 1992 Jan; 42(2):201-7. PubMed ID: 1346349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high proportion of ADA point mutations associated with a specific alanine-to-valine substitution.
    Markert ML; Norby-Slycord C; Ward FE
    Am J Hum Genet; 1989 Sep; 45(3):354-61. PubMed ID: 2773932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.